Inventor · disambiguated record
Stefan H. I. Kappe
Also filed as: KAPPE STEFAN · KAPPE STEFAN H · KAPPE STEFAN H I
9 granted patents·6 pending applications·62 citations·filing 1997–2022
85Inventor score
Files withSEATTLE BIOMEDICAL RES INST3SEATTLE CHILDRENS HOSPITAL2SEATTLE CHILDRENS HOSPITAL D/B/A SEATTLE CHILDRENS RES INSTITUTE2UNIV RUPRECHT KARLS HEIDELBERG2DUFFY PATRICK1
Top patents by PatentIndex Score
15 records- 0191US7122179B2Live genetically attenuated malaria vaccineUNIV RUPRECHT KARLS HEIDELBERG·Filed 2005·Granted Oct 17, 2006·19 cites·1 claims
- 0282US7722860B2Live genetically engineered protozoan vaccineSEATTLE BIOMEDICAL RES INST·Filed 2005·Granted May 25, 2010·4 cites·5 claims
- 0380US7261884B2Live genetically attenuated malaria vaccineUNIV RUPRECHT KARLS HEIDELBERG·Filed 2006·Granted Aug 28, 2007·2 cites·1 claims
- 0477US6120770APlasmodium proteins useful for preparing vaccine compositionsUNIV NOTRE DAME DU LAC·Filed 1997·Granted Sep 19, 2000·33 cites·6 claims
- 0567US8318183B2Plasmodium liver stage antigensDUFFY PATRICK·Filed 2010·Granted Nov 27, 2012·2 cites·5 claims
- 0663US7718165B2Live genetically attenuated malaria vaccineSEATTLE BIOMEDICAL RES INST·Filed 2004·Granted May 18, 2010·2 cites·2 claims
- 0758US11529404B2Doubly attenuated late liver stage malaria parasites and related compositions and methodsSEATTLE CHILDRENS HOSPITAL·Filed 2021·Granted Dec 20, 2022·0 cites·19 claims
- 0857US2023045390A1Plasmodium vivax male gamete fusion protein pvhap2 and the putative proliferating-cell nucleolar antigen p120 as relapse biomarkersSEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST·Filed 2022·Application pending·0 cites
- 0954US10905753B2Doubly attenuated late liver stage malaria parasites and related compositions and methodsSEATTLE CHILDRENS HOSPITAL·Filed 2018·Granted Feb 2, 2021·0 cites·15 claims
- 1053US2024382573A1Compositions incorporating a genetically attenuated plasmodium with modified liver stage nuclear protein (linup) and related methodsSEATTLE CHILDRENS HOSPITAL D/B/A SEATTLE CHILDRENS RES INSTITUTE·Filed 2022·Application pending·0 cites
- 1152US2005233435A1Plasmodium axenic liver stages as a noninfectious whole organism malaria vaccineNYU MEDICAL CT·Filed 2004·Application pending·0 cites
- 1246US2023390372A1Compositions and methods for targeting plasmodium male gamete protein to block malaria parasite transmissionSEATTLE CHILDRENS HOSPITAL D/B/A SEATTLE CHILDRENS RES INSTITUTE·Filed 2021·Application pending·0 cites
- 1345US2010210004A1Plasmodium axenic liver stages as a noninfectious whole organism malaria vaccineUNIV NEW YORK·Filed 2010·Application pending·0 cites
- 1440US8168166B2Live genetically attenuated malaria vaccineKAPPE STEFAN H I·Filed 2008·Granted May 1, 2012·0 cites·1 claims
- 1538US2017056422A1Plasmodium liver-stage inhibitors and related methodsSEATTLE BIOMEDICAL RES INST·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stefan H. I. Kappe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →